CANCER CHEMOTHERAPY ACENAPHTHENE ... - Cancer Research

Downloaded from cancerres.aacrjournals.org on August 30, 2013. © 1956 American Association for Cancer
Research.
37
CARBAMATE, ETHYL —¿ THERAPY (Continued)
604 Van Eck, W. F. and De Vries, S. I. URETHAAN-
BEHANDELING VAN LEUCAEMIEEN. [UKETHANE
TREATMENT OF LEUKEMIAS.] Ned. tschr. geneesk.,
1948, 3: 2387-2399. Abstracted in: Excerpta
med., Sect. 7, 1949, 3: No. 2086.
605 Viarengo, G. CASI DI LEUCEMIA TRATTATI CON
ETILURETANO. [LEUKEMIA CASES TREATED WITH
ETHYLURETHANE.] Minerva med.. Tor., 1949
40: pt. 2, 294-295.
606 Videbaek, A. OM URETHANBEHANDLING AF LEUKAEMI.
[URETHANE THERAPY OF LEUKEMIA.] Nord, med
1947, 33: 680-681. Abstracted in: Excerpta'
med., Sect. 2, 1948, 1; No. 3241.
607
Vlados, Kh. Kh., lUrovskaia, I. I., Shamshina,
E. V. and Shvedskii, B. P. LECHENIE KHRONI-
CHESKIKH LEUKOZOV URETANOM. [TREATMENT OF
CHRONIC LEUKEMIAS WITH URETHANE.] Ter. arkh.,
daily
Moskva,
doses
1949,
of~Z-6
21: No.
g was
6,
administered
78-85. Urethane
to 32
in
patients with chronic myeloid and 9 patients
with chronic lymphoid leukemia. The treat
ment was most successful in patients with
myeloid leukemia and in those not previously
treated with X-rays.
608
Vries, S. I. de BEHANDELINGVANACUTELEUCAEMIE.
[THE TREATMENTOF ACUTELEUKEMIA.] Ned. tschr.
geneesk., 1950, 94: 1619-1628. Abstracted in:
Biol. Abstr., Barf., 1951, 25: No. 17372.
609 Vries, S. I. de BEHANDELING VAN CHRONISCHE
LYMPHATISCHE LEUCAEMIE MET URETHAN. [URE
THANE TREATMENT OF LYMPHATIC LEUKEMIA.] -
Ned. tschr. geneesk., 1953, 97: 2330-2338.
8 refs. Abstracted in: Leukemia Abstr.,
1953, 1.:No. 385. "...the author observed
prolonged remissions in 12 out of 14 cases
of chronic lymphatic leukemia treated with
urethane...The remissions, which in some
cases lasted 24-40 months, included both
the clinical conditions and the blood
pictures..." - Leukemia Abstr.
610
WaSlschíÕZ"•and Cutmannova, H. LÉOENÕ
CHRONICtíMYELOICKÉLEUKEMIE URETHANEM
[TREATMENT OF CHRONIC MYELOID LEUKEMIA
WITH URETHANE.] Cas. lek. fiesk.,1946
85j 1742-1746. 2 refs. The patient,
a female, age 22, was treated exclusive
ly with urethane in a total amount of 73
mg during 21 days. The size of the spleen
diminished, the leukocyte count decreased
and the HB rose from 54% to 93%
611 Watkins, C. H., Cooper, T. and Giffin. H. Z.
THE USE OF URETHANE IN THE TREATMENT OF LEU
KEMIA; A PRELIMINARY REPORT. Blood, Bait
1948, 3: 892-895.
612
Webster, J. J. URETHANE IN LEUKEMIA. J. Am.
M. Ass., 1947, 135: 901-903. 14 refs. A
man, aged 59, with chronic myelogenous leu
kemia was treated first with X-rays, and
six months later with urethane. In 3 mg
daily doses urethane was administered over
a period of 39 days. The drug caused se
lective inhibition of early myeloid cells
and a decrease in the size of the spleen.
Patient died of granulocytopenia 14 days
after treatment ceased.
613 Weder, C. URETHANE IN THE TREATMENT OF MULTIPLE
MYELOMA.
590. réf.
Cañad.M.
Urethane
Ass.
given
J..
in
1950,
0.5 g~capsules
62: 589-
daily and in total doses of 1.5 g-4 g over a
series of treatments, produced clinical,
histological, biochemical and hematological
improvement after failure to arrest the disease
with stilbamidine.
614
Weicker, H. LEISTUNGSFÄHIGKEIT UND GRENZEN DER
MITOSEGIFT-THERAPIE BEI DEN LEUKOSEN, LYMPHO-
GRANULOMATOSENUND MALIGNEN GESCHWULSTEN DES
KINDESALTERS. [EFFECTIVENESS AND LIMITS OF
THE TREATMENT WITH MITOTIC POISONS OF LEUKE
MIA, HODGKIN'S DISEASE AND MALIGNANT TUMOURS
IN CHILDREN.] Kinderarztl. Prax., 1950, 18:
Sonderhft., 143-150. Bibliography: p. ~
150.
615
Weir, D. R. and Heinle, R. W. EFFECT OF URE
THAN ON TRANSPLANTED LEUKEMIA OF AK MICE.
Proc. Soc. Exp. Biol., N. Y., 1947, 66:
268-270. Abstracted in: Chem. AbstrTT 1948
42: 986Ì.
616
Yamamoto, T. and Komatu, K. URETHANE TREAT
MENT OF ACUTE MEDULLARY LEUKEMIA. Rinsyo
naika syonika, 1949, 4: 164-168. réf.
In Japanese.
•¿17
Zwetschke, O. NASE ZKUSENOSTI S LÉCENÕMLEU-
KEMII. [OUR.EXPERIENCE IN THE TREATMENT OF
LEUKEMIA.] Cas. lek. cesk., 1948, 87: 1021-
1027. 13 refs. English summary. ''Chronic
lymphatic and myeloid leukemia in 12 patients
were treated with daily doses of 3-4 g ure
thane. Nine cases were successful, 3 cases,
mostly lymphatic leukemia,were unsuccessful.
In 2 cases of lymphatic leukemia a rapid
decrease of red blood cells occurred, and
granulocytes disappeared completely from
the peripheral blood. Both cases ended
fatally."
See:
1253351099157620162259238831111334211228184920172299240532091344241252
THERAPY, ENHANCEMENT
618 Balduini, M. IL MIDOLLO OSSEO ED IL SANGUE
PERIFERICO NELLA INTOSSICAZIONE SPERIMENTALE
CON URETANO ETILICO. [THE BONE MARROW AND
THE PERIPHERAL BLOOD IN EXPERIMENTAL ETHYL
URETHANE POISONING.] Haematologica, Pavía,
1949, 33: 55-70. 30 refs. English summary.
619
Bertrand, I. and (Juivy, D. LÉSIONSEXPERIMEN
TALES OBSERVÉES CHEZ LE LAPIN APRÈSURÊTHANE.
[EXPERIMENTALLESIONS OBSERVEDIN THE RABBIT
AFTER URETHANE.] C. rend. Soc. biol., 1950,
ÄT5s~tr.,
144: 482-483.
1951, 45:
1 réf.
261h.
Abstracted in: Chem.
Bertrand, I. and Quivy, D. SUR LES LÕSIONSEX
PÉRIMENTALES OBSERVEESCHEZ LE RAT APRES URE
THANE. [EXPERIMENTALLESIONS OBSERVEDIN RATS
GIVEN URETHANE.] C. rend. Soc. biol., 1950,
144: 368-370. 12 refs. Abstracted in: Chem.
IbTtr., 1951, 45: 261g.
See:
693
OF